platinum has been researched along with aclarubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebihara, T; Fukushima, M; Kawakami, S; Maruyama, K; Sawada, T; Tateyama, Y; Yoshimura, Y | 1 |
| Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K | 1 |
2 other study(ies) available for platinum and aclarubicin
| Article | Year |
|---|---|
[Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma].
Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Catheterization; Cisplatin; Embolization, Therapeutic; Evaluation Studies as Topic; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Platinum; Remission Induction; Tissue Distribution; Uterine Cervical Neoplasms | 1989 |
[CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
Topics: Abdominal Neoplasms; Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Platinum; Recurrence; Remission Induction; Thrombocytopenia | 1989 |